Regeneron Pharmaceuticals (REGN)

Market Cap

$83.09B

Current · Retrieved: · USD

REGN logo

REGN Market Cap

Current$83.09B
REGN Market Cap ($1.83B → $83.09B · CAGR +11.3%)
High-resolution chart · PNG

REGN market cap history

Daily history. Dates identify market observations.

Regeneron Pharmaceuticals Market Cap — Daily history
DateMarket Cap
123,541,274,250
123,515,522,965
122,335,084,066
122,096,112,142
122,805,817,554
123,284,791,453
121,474,991,151
121,065,030,695
119,162,525,767
119,313,943,322
115,478,031,925
116,523,534,091
114,680,772,144
109,988,888,037
109,823,049,762
110,347,345,922
111,471,131,995
112,599,038,273
111,162,116,576
111,018,939,432
110,956,106,297
111,104,433,698
109,617,039,483
109,274,032,368
108,729,135,180
110,188,718,007
109,556,266,450
109,933,265,261
111,824,439,624
112,789,597,782
111,462,891,584
113,310,803,788
111,273,362,127
110,330,865,100
108,570,507,265
108,387,158,116
106,531,005,501
105,486,533,386
107,605,349,107
108,878,492,632
108,261,491,846
108,243,980,972
110,128,975,026
110,338,075,460
109,586,137,941
108,478,832,691
107,577,537,719
107,033,670,582
107,678,482,756
106,766,887,271
105,739,926,029
105,855,291,786
104,090,813,745
103,183,338,465
103,309,004,735
103,086,513,634
103,609,779,743
102,313,975,087
101,921,525,505
100,961,517,604
99,905,714,924
99,553,437,346
100,240,481,627
101,462,122,583
101,003,749,712
101,336,456,312
102,381,958,479
101,693,884,147
101,180,918,552
99,706,915,004
100,760,657,582
101,422,980,630
100,631,901,158
100,306,404,917
99,708,975,107
98,448,192,199
99,911,895,232
98,744,847,001
98,575,918,572
96,578,648,916
93,063,083,502
91,742,557,613
91,930,026,967
90,974,139,271
91,744,617,715
93,378,279,229
93,458,623,238
92,721,106,439
92,377,069,272
92,085,564,727
92,827,201,732
92,101,015,498
92,556,298,215
93,188,749,772
94,797,690,052
96,433,411,669
97,225,521,192
96,668,263,387
97,102,945,076
96,517,875,883
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.